发明名称 11-(2-PYRROLIDIN-1-YL-ETHOXY)-14,19-DIOXA-5,7,26-TRIAZA-TETRACYCLO[19.3.1.1(2,6)1(8,12)]HEPTACOSA-1(25),2(26),3,5,8,10,12(27),16,21,23-DECAENE CITRATE SALT
摘要 The present invention relates to certain salts of a 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (Compound I) which have been found to have improved properties. In particular the present invention relates to the citrate salt of this compound. The invention also relates to pharmaceutical compositions containing the citrate salt and methods of use of the citrate salt in the treatment of certain medical conditions.
申请公布号 HRP20150428(T1) 申请公布日期 2015.06.19
申请号 HR2015P000428T 申请日期 2015.04.20
申请人 CTI BIOPHARMA CORP. 发明人 DYMOCK, BRIAN;LEE, CHENG HSIA ANGELINE;WILLIAM, ANTHONY DEODAUNIA
分类号 C07D498/04;A61K31/519;A61P35/00 主分类号 C07D498/04
代理机构 代理人
主权项
地址